Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Striatal oligodendrogliogenesis and neuroblast recruitment are increased in the R6/2 mouse model of Huntington's disease.

Brain research | 2013

The subventricular zone (SVZ) is one of the two major neurogenic regions in the adult mammalian brain. Its close proximity to the striatum suggests that a cell-based therapeutic strategy for the treatment of Huntington's disease (HD) is possible. To achieve this, it is important to understand how adult cell production, migration and differentiation may be altered in the HD brain. In this study, we quantified the number of adult-born striatal cells and characterized their fate in the R6/2 transgenic mouse model of HD. We found that the number of new striatal cells was approximately two-fold greater in R6/2 vs. wild type mice, while SVZ cell proliferation was not affected. Using cell-type specific markers, we demonstrated that the majority of new striatal cells were mature oligodendrocytes or oligodendroglial precursors that were intrinsic to the striatum. We also detected a significant increase in the number of migrating neuroblasts that appeared to be recruited from the SVZ to the striatum. However, these neuroblasts did not mature into neurons and most were lost between 1 and 2 weeks of cell age. Crossing the R6/2 mice with mice the over-expressing brain-derived neurotrophic factor in the striatum increased the numbers of neuroblasts that survived to 2 weeks, but did not promote their differentiation. Together, our data indicate that the potential treatment of HD based on manipulating endogenous progenitor cells should take into consideration the apparent enhancement in striatal oligodendrogliogenesis and the limited ability of recruited SVZ neuroblasts to survive long-term and differentiate in the diseased striatum.

Pubmed ID: 23623813 RIS Download

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Adobe Illustrator (tool)

RRID:SCR_010279

Vector graphics software to create digital graphics, illustrations, and typography for several types of media: print, web, interactive, video, and mobile.

View all literature mentions

Mouse Anti-S100B Monoclonal, Unconjugated, 1B2 (antibody)

RRID:AB_10013751

This monoclonal targets Mouse S100B 1B2

View all literature mentions

Anti-CNPase, clone 11-5B (antibody)

RRID:AB_2082608

This monoclonal targets Cnp

View all literature mentions

Anti-Glial Fibrillary Acidic Protein (GFAP) (antibody)

RRID:AB_2109645

This polyclonal targets Glial Fibrillary Acidic Protein (GFAP)

View all literature mentions

Anti-NeuN (antibody)

RRID:AB_2298772

This monoclonal targets NeuN

View all literature mentions

Monoclonal Anti-Calbindin-D-28K antibody produced in mouse (antibody)

RRID:AB_476894

This monoclonal targets Calbindin-D-28K antibody produced in mouse

View all literature mentions

ANTI-OLIG-2 (antibody)

RRID:AB_570666

This polyclonal targets Oligodendrocute transcription factor 2

View all literature mentions

PCNA (F-2) (antibody)

RRID:AB_628109

This monoclonal targets PCNA

View all literature mentions

Anti Iba1, Rabbit antibody (antibody)

RRID:AB_839504

This polyclonal targets Iba1

View all literature mentions

Anti-Synuclein, alpha, clone 7B12.2 (antibody)

RRID:AB_95210

This monoclonal targets Synuclein alpha clone 7B12.2

View all literature mentions